SAN DIEGO, May 30, 2012 /PRNewswire/ -- Accelrys, Inc. (NASDAQ: ACCL), a leading enterprise R&D software and services company, today announced that the Gulf Coast Consortia (GCC) for Quantitative Biomedical Sciences has signed a five-year licensing agreement with Accelrys to provide investigators in the GCC Chemical Genomics (GCC-CG) program with access to scientific software, services and training. The Accelrys software will be used to support multi-disciplinary collaborative research and training programs for the treatment and prevention of diseases, including rare and undertreated cancers.
To view the multimedia assets associated with this release, please click http://www.prnewswire.com/news-releases/accelrys-announces-software-licensing-agreement-with-gulf-coast-consortia-155506635.html
Offered through the Accelrys Academic Program, the licensed software includes the scientifically enabled, enterprise-scalable Accelrys Enterprise Platform supporting multi-center, collaborative information sharing and scientific innovation across partnering research organizations. The system also includes Accelrys Pipeline Pilot™ (the platform's scientific authoring solution), the Cloud-based Accelrys HEOS® drug discovery information management workspace, the Accelrys Discovery Studio® modeling and simulation application and Accelrys Biological Registration software.
"Plug-and-play deployment and ease of use in a seamless integrated network requiring minimal support by internal resources were the driving factors that led our group to adopt Accelrys technology," said GCC-CG director and co-founder Dr. Peter Davies, professor and director of the Center for Translational Cancer Research, Institute of Biosciences and Technology, Texas A&M Health Center. "With upwards of thirty projects a year, we need to work together efficiently and generate results quickly with minimal time and resources spent on internal software development. The ability to create Pipeline Pilot Web applications that can be freely shared with other academic researchers inside or outside the Consortia provides a significant collaboration and innovation benefit."Dr. Michael Mancini, associate professor in the department of Molecular and Cellular Biology at Baylor College of Medicine, and co-founder/co-director of the GCC-CG added "For several years, our assay development efforts and screening program have always had a sizable high throughput microscopy-based emphasis using Pipeline Pilot-based imaging tools. We are extremely pleased to now be able to integrate high content analysis/screening data and reporting across the entire program using HEOS." The mission of the GCC is to build and support interdisciplinary collaborative research teams and training programs in the biological sciences and apply the resulting expertise and knowledge to the treatment and prevention of diseases. The GCC brings together preeminent principal investigators from several world-renowned research institutions including the founding members:
- Baylor College of Medicine
- Rice University
- University of Houston
- University of Texas Health Science Center at Houston (UTHealth)
- University of Texas MD Anderson Cancer Center
- University of Texas Medical Branch at Galveston
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV